SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (100)1/9/2001 2:47:04 PM
From: Pseudo Biologist  Read Replies (1) of 1022
 
Let me park this here before I lose it again:

smartmoney.com

Focuses on MEDX and ABGX, brief mention of others.

A snippet: Assuming both Abgenix and Medarex "are probably equivalent in the number of deals and the number of products in development from these deals, there's no way to say which one will be the overwhelming winner," said Camilo Martinez, co-manager of the Dresdner RCM Biotechnology fund (DRBNX9). Says Faraz Naqvi, Martinez's co-manager: "The valuation and relative price of Medarex make it a more compelling buy."

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext